# C2i Genomics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/c2i-genomics

- Industry: Healthcare IT
- Headquarters: New York, US
- Website: www.c2i-genomics.com
- Total disclosed funding: $112M
- Latest round: Series B (Apr 14, 2021)
- Investors on record: 10

## About

Based in New York, US, and founded in 2019, C2i Genomics, Inc. operates as a healthcare company that provides cloud-based cancer diagnostic solutions for pharmaceutical and diagnostic sectors. The company was founded by Asaf Zviran, Boris Oklander, Dan Landau, and Ezra Sofer. In January 2024, Veracyte Inc. agreed to acquire C2i Genomics, Inc. from Casdin Capital, NFX, The Mark Foundation for Cancer Research, Alexandria Venture Investments, Driehaus Capital Management LLC, Duquesne Family Office, iGlobe Partners, LionBird, Section 32, and Silver Lake for USD 95 million.


The company provides a Saas platform that uses AI pattern recognition and whole-genome analysis that helps physicians to detect treatment failure and monitor patient treatment response.

## Funding rounds

- Series B, Apr 14, 2021, $100M — Silver Lake, Alexandria Venture Investments, iGlobe Partners, Driehaus Capital Management, Casdin Capital, LionBird, Duquesne Family Office, NFX, Section 32, Mark Foundation for Cancer Research
- Series A, May 22, 2020, $12M — Casdin Capital, NFX, Mark Foundation for Cancer Research

## Investors

- Casdin Capital (https://capitalatlas.ai/funds/casdin-capital) — Series A, Series B
- NFX (https://capitalatlas.ai/funds/nfx) — Series A, Series B
- Mark Foundation for Cancer Research — Series A, Series B
- Silver Lake (https://capitalatlas.ai/funds/silver-lake) — Series B
- Alexandria Venture Investments (https://capitalatlas.ai/funds/alexandria-venture-investments) — Series B
- iGlobe Partners (https://capitalatlas.ai/funds/iglobe-partners) — Series B
- Driehaus Capital Management (https://capitalatlas.ai/funds/driehaus-capital-management) — Series B
- LionBird (https://capitalatlas.ai/funds/lionbird) — Series B
- Duquesne Family Office — Series B
- Section 32 (https://capitalatlas.ai/funds/section-32) — Series B